{"title": "Climatic influences on the worldwide spread of SARS-CoV-2", "doi": "10.1101/2020.03.19.20038158", "citation_id": "2020.03.19.20038158v1", "date": "2020-03-23", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.03.19.20038158", "abstract": "<p>The rapid global spread of the novel, pathogenic, SARS-CoV-2 causing the severe acute respiratory disease COVID-19, becomes a major health problem worldwide and pose the need for international predictive programs. Given the lack of both specific drugs and an efficient preventive vaccine, the expectation that the SARS-CoV-2 transmission rate might decrease in temperate regions during summer, dominated in the social scene. Here, we attempted a prediction of the worldwide spread of the infections based on climatic data, expressed by bioclimatic variables. The calculated probability maps shown that potential areas of infection follow a shift from the Tropical to Temperate and Mediterranean Bioclimatic regions. Maps show an increased probability of infections in Europe, followed by an expansion covering areas of the Middle East and Northern Africa, as well as Eastern coastal areas of North America, South-Eastern coastal areas of Latin America and two areas of Southern Australia. Our approach may, therefore, be of value for the incorporation of climatic influences in the design and implementation of public health policies. Maps are available (constantly updated) at https://navaak.shinyapps.io/CVRisk/.</p>", "twitter_description": "The rapid global spread of the novel, pathogenic, SARS-CoV-2 causing the severe acute respiratory disease COVID-19, becomes a major health problem worldwide and pose the need for international predictive programs. Given the lack of both specific drugs and an efficient preventive vaccine, the expectation that the SARS-CoV-2 transmission rate might decrease in temperate regions during summer, dominated in the social scene. Here, we attempted a prediction of the worldwide spread of the infections based on climatic data, expressed by bioclimatic variables. The calculated probability maps shown that potential areas of infection follow a shift from the Tropical to Temperate and Mediterranean Bioclimatic regions. Maps show an increased probability of infections in Europe, followed by an expansion covering areas of the Middle East and Northern Africa, as well as Eastern coastal areas of North America, South-Eastern coastal areas of Latin America and two areas of Southern Australia. Our approach may, therefore, be of value for the incorporation of climatic influences in the design and implementation of public health policies. Maps are available (constantly updated) at https://navaak.shinyapps.io/CVRisk/.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nNo funding support\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nData are online available from the sources which are described in the text", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.19.20038158v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.03.19.20038158v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.19.20038158v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/23/2020.03.19.20038158.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.03.19.20038158v1", "access_rights": "restricted", "authors": ["Michail Bariotakis", "George Sourvinos", "Elias Castanas", "Stergios A Pirintsos"]}